Get Charles River Laboratories International alerts:Check Out Our Latest Stock Analysis on CRLCharles River Laboratories International Stock PerformanceNYSE CRL opened at $175.41 on Thursday. Charles River Laboratories International (NYSE:CRL – Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. On average, equities analysts forecast that Charles River Laboratories International will post 9.36 earnings per share for the current year. About Charles River Laboratories International(Get Free Report)Charles River Laboratories International, Inc provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. Read MoreReceive News & Ratings for Charles River Laboratories International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles River Laboratories International and related companies with MarketBeat.com's FREE daily email newsletter.